Vaccines

Aug 13, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.
Jul 24, 2015
By Pharmaceutical Technology Editors
EMA gives GSK’s malaria candidate vaccine a positive opinion for the prevention of malaria in young children in sub-Saharan Africa.
Jul 16, 2015
By Pharmaceutical Technology Editors
GSK accelerates delivery timeline for US quadrivalent flu vaccine.
Jul 13, 2015
By Pharmaceutical Technology Editors
The European Medicines Agency reviews the safety of human papillomavirus vaccines.
Jul 07, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A study now underway on vaccine manufacturing examines the effects of focusing on consistency during manufacturing, instead of post-production testing.
Jun 25, 2015
By Pharmaceutical Technology Editors
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
May 21, 2015
By Pharmaceutical Technology Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 11, 2015
By Pharmaceutical Technology Editors
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
Apr 27, 2015
By Pharmaceutical Technology Editors
Catalent’s Zydis technology will be used to develop thermo-stable and cold-chain independent vaccines.
Apr 20, 2015
By Pharmaceutical Technology Editors
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
native1_300x100
lorem ipsum